{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for m root_names_stdName in Standardized Name (approximate match)
Status:
Investigational
Source:
INN:miromavimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
USAN:MAVEROPEPIMUT-S COMPONENT SURA2.M [USAN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:tozorakimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:efruxifermin [INN]
Source URL:
Class:
PROTEIN
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT01342263: Not Applicable Interventional Completed Ischemic Heart Disease
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:davoceticept [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:dargistotug [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN